Philips to Grow its Presence in the Anesthesia Market with the Acquisition of Dameca

Royal Philips ElectronicsRoyal Philips Electronics (AEX: PHI, NYSE: PHG) has acquired Dameca, a global provider of anesthesia machines and accessories for the operating room. This acquisition marks an important step in the execution of Philips' strategy to expand its portfolio with integrated, advanced anesthesia care solutions.

Along with Philips' expertise and well-established position in patient monitoring, interventional imaging systems, and clinical informatics solutions, Dameca further broadens Philips' current portfolio and provides opportunity for innovation in such areas as anesthesia-related clinical decision support. Philips currently offers anesthesia machines in select countries through Dixtal Medical, which Philips acquired in 2008.

"The acquisition of Dameca is a proofpoint of Philips' growth strategy and ambitions to expand our anesthesia care offerings by combining our strengths in patient monitoring, therapeutic care, and clinical informatics," said Steve Rusckowski, CEO for Philips Healthcare. "Dameca's anesthesia machines are a significant complement to our current operating room portfolio and will enable us to offer an integrated solution that will simplify clinician workflow, improve financial outcomes for our customers, and help improve patient care."

Headquartered in Copenhagen, Denmark, Dameca was founded in 1947 and is a privately held company with approximately 70 employees. Its current product line includes anesthesia machines, wall panels, pendant systems, flow meters, suction units, and other accessories. The company uses direct sales channels in the Nordic countries, and serves over 60 countries globally through distributors. Financial terms of the acquisition were not disclosed.

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs 119,000 employees in more than 60 countries worldwide. With sales of EUR 25.4 billion in 2010, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare.

Most Popular Now

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Detecting Lung Cancer 4 Months Earlier a…

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case. The GP should be able...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

NHS, Councils, and Housing could Share N…

A new technology partnership formally announced, could help NHS, local government, and housing organisations collaborate to create an unprecedented understanding of the risks and needs of people in their care...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

An AI Tool Grounded in Evidence-Based Me…

A powerful clinical artificial intelligence tool developed by University at Buffalo biomedical informatics researchers has demonstrated remarkable accuracy on all three parts of the United States Medical Licensing Exam (Step...

AXREM and BHTA Name Highland as 'Fu…

Hosted by trade associations AXREM and the British Healthcare Trades Association (BHTA), 'The Future of MedTech - Innovating for Tomorrow', will allow delegates to engage with speakers from the government...